News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Patients progressing on 1L palbo should not receive further exposure to palbo- Paolo Tarantino
Photo: Paolo Tarantino/Twitter
Jun 10, 2023, 02:53

Patients progressing on 1L palbo should not receive further exposure to palbo- Paolo Tarantino

Consistent with the PACE trial, the PALMIRA randomized phase 2 trial showed no benefit in terms of PFS or OS with the use of palbociclib beyond progression to 1L ET+palbo. Patients progressing on 1L palbo should not receive further exposure to palbo. #ASCO23

Source: Paolo Tarantino/Twitter

ASCO23 palbo palbociclib Palmira Paolo Tarantino
Special Coverage
Insight
Nov 15, 2024, 17:12
Jarushka Naidoo: The largest study evaluating association between specific irAEs and IO outcomes
Blog
Nov 15, 2024, 16:49
Long-Term Outcomes of Mini-CHOP Plus Anti-CD20 in Elderly DLBCL Patients
Blog
Nov 15, 2024, 16:48
Amil Družić: Key Takeaways from the Franco-Bosnian Air Quality Conference
Blog
Nov 15, 2024, 16:44
Sandra Silvestri: Did you know that NET account for 20% of lung cancers
Blog
Nov 15, 2024, 16:42
When Cancer and Cardiovascular Disease Intersect
Blog
Nov 15, 2024, 16:41
Rahul Gosain: Current treatment landscape for NET with Pamela Kunz
Insight
Nov 15, 2024, 16:34
More young people are surviving cancer, then they face a life altered by it
Blog
Nov 15, 2024, 16:33
Richi Childhood Cancer Foundation - Providing essential support to families of children with life-threatening illnesses
Insight
Nov 15, 2024, 16:30
Virginia Kakla Mani: New Screening Practices and Therapeutic Insights for HR+ Breast Cancer
Insight
Nov 15, 2024, 16:24
Implementation of lifestyle medicine into multidisciplinary care to improve survivorship - Cancer Network
Blog
Nov 15, 2024, 16:21
Only 1 week left until the EORTC webinar on innovative study designs for older adults
Opinion
Nov 15, 2024, 16:18
Erika Hamilton: Harold Burstein and Thomas Grinda on anthracyline use in early breast cancer